Hipa.ai

What Hipa.ai does

Hipa.ai, operated by Botmakers LLC, is a U.S.-based clinical trials discovery engine that aggregates recruiting studies from ClinicalTrials.gov via the AACT (Aggregate Analysis of ClinicalTrials.gov) database. The platform indexes 27,375 active trials across all 50 U.S. states, Washington D.C., and 30+ major cities, with state-, city-, condition-, age-, and sponsor-level filtering. Data is synced daily from ClinicalTrials.gov with weekly full refresh cycles, and listings link directly to the sponsoring research site on ClinicalTrials.gov without gating.

The product surface extends beyond the trial directory into two content products: monthly national, state, and city-level Clinical Trials Research Reports analyzing new postings, closing deadlines, top conditions, and healthy-volunteer opportunities, and weekly Behavioral Health Workforce News covering BCBA and RBT enrollment from the CMS NPI registry. A Microsoft Store desktop app supplements the web platform. The company has no disclosed patents, certifications, funding, or named management team and operates with 1–10 employees.

The business model is freemium on the consumer side — patients and healthy volunteers browse, filter, and apply to trials free of charge — paired with a B2B monetization layer for pharmaceutical sponsors, contract research organizations, and research sites. B2B revenue is generated through quote-based sponsored placements, featured listings, and enrollment campaigns. There is no publicly disclosed revenue, no disclosed paying customers, and no disclosed pricing for the B2B offerings. Distribution is primarily organic search and content marketing, with the Microsoft Store app as a secondary channel.

Name

Hipa.ai

Legal name

Botmakers LLC

Website

https://hipa.ai

Company type

Private

Founded year

2026

Operating status

Operating

Headcount range

1–10 employees

Short description

Hipa.ai (Botmakers LLC) operates a free U.S. clinical trials discovery engine aggregating 27,375 active studies from ClinicalTrials.gov across all 50 states and 30+ cities, monetizing via B2B sponsored placements, enrollment campaigns, and workforce data reports.

Ownership category

akta.pro rank

Product category

Clinical Trial Discovery Platform

NAICS

Advertising Agencies (541810)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Clinical Trial Patient Recruitment & Retention (HLAGACAD)

akta.pro secondary industry

Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

Keywords

• Clinical trial discovery
• Clinical trial search
• Patient recruitment platform
• Clinical trial directory
• Behavioral health analytics

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Free Consumer Access: Free clinical trials discovery directory for patients and healthy volunteers. Users can browse, filter, and apply to trials at no charge.
2. Sponsored Placements for Sponsors: B2B revenue from pharmaceutical sponsors, contract research organizations (CROs), and research sites purchasing sponsored placements and featured listing positions within state and city directories.
3. Enrollment Campaigns: Premium B2B services for sponsors and research sites to run enrollment campaigns and improve discoverability of their recruiting trials across Hipa.ai's directories.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Hipa.ai operates a free, consumer-facing clinical trials discovery platform that aggregates 27,375+ actively recruiting studies from ClinicalTrials.gov via the AACT database, organized by U.S. state, city, and condition. The platform is supplemented by monthly clinical trials research reports and weekly BCBA/RBT behavioral health workforce analytics built from CMS NPI data. For B2B customers, Hipa.ai sells sponsored placements, featured listings, and enrollment campaign services to pharmaceutical sponsors, contract research organizations, and research sites.

Product overview

Hipa.ai is a clinical trials discovery engine built and operated by Botmakers LLC. The platform consists of a unified web directory — the Paid Clinical Trials Discovery Platform — that aggregates recruiting studies from ClinicalTrials.gov (via the AACT database) and is refreshed weekly. The core product is supplemented by Clinical Trials Research Reports (monthly state/city-level analysis), Behavioral Health Workforce News (weekly BCBA/RBT hiring reports from CMS NPI data), and a Microsoft Store desktop application. Sponsors, CROs, and research sites can also contact Hipa.ai for sponsored placements across the directory.

Differentiator

Problem solved

Functional benefit

Products and services

• Paid Clinical Trials Discovery Platform Free clinical trials discovery directory that aggregates 27,375+ recruiting studies from ClinicalTrials.gov (via the AACT database) and exposes them through state, city, and condition pages with filtering by age, healthy-volunteer eligibility, and sponsor. Built for U.S. patients with medical conditions and healthy volunteers looking for paid participation opportunities.
• Clinical Trials Research Reports Monthly national, state, and city-level analysis reports on recruiting clinical trials in the United States, including counts of new postings, studies closing within 90 days, top conditions, and healthy-volunteer opportunities. Published as content for SEO and as supporting evidence for the B2B audience.
• Behavioral Health Workforce News Weekly analysis of BCBA (Board Certified Behavior Analyst) and RBT (Registered Behavior Technician) hiring and enrollment data sourced from the CMS National Provider Identifier (NPI) registry, with breakdowns by state and metropolitan area for the U.S. behavioral health workforce.
• Hipa.ai Microsoft Store App Native Windows desktop application distributed through the Microsoft Store that allows users to search and browse the Hipa.ai clinical trials directory on local Windows devices.

Quantifiable outcome

• 27,375 actively recruiting clinical trials listed across the United States
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• ClinicalTrials.gov / AACT DatabasecoreTechnology or IntegrationHipa.ai sources all clinical trial data from ClinicalTrials.gov via the AACT (Aggregate Analysis of ClinicalTrials.gov) database. This partnership provides the foundational data layer for the entire platform, enabling comprehensive trial listings across all U.S. states. Data is synced daily with weekly full refreshes.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Smart Patients: Smart Patients is an online patient community that surfaces clinical trial information alongside peer discussions. It overlaps with Hipa.ai on trial discovery but emphasizes community/support rather than directory navigation.
• TrialX: TrialX (xCures/Trial Library) provides clinical trial matching and patient recruitment solutions, including EMR-based eligibility matching. It is an emerging peer with overlapping patient-recruitment and sponsor-facing capabilities.

Direct peers

• CureClick: CureClick runs a community-driven clinical trial recruitment platform connecting patients with actively recruiting studies. It overlaps Hipa.ai's patient-recruitment directory and sponsor B2B services.
• ClinicalConnection: ClinicalConnection is a clinical trial matching platform where volunteers sign up to be matched with recruiting studies. It directly overlaps Hipa.ai's consumer-facing free discovery and volunteer recruitment use cases.
• EmergingMed: EmergingMed provides clinical trial navigation and matching services for cancer and other serious conditions, including call-center supported enrollment. It is a direct competitor for patient-side trial discovery and sponsor recruitment support.
• CenterWatch: CenterWatch is a long-established clinical trial listing service providing directories, patient education, and trial awareness tools. It competes with Hipa.ai in serving both patients seeking trials and sponsors seeking recruitment visibility.
• Antidote: Antidote operates a clinical trial matching and patient recruitment platform that connects patients to recruiting studies via condition/zip-based search. It is a direct competitor to Hipa.ai's trial discovery and B2B sponsor-facing services.

Broad incumbents

• IQVIA: IQVIA is the largest global CRO and offers enterprise clinical trial recruitment, analytics, and technology platforms. It does not directly overlap Hipa.ai's consumer directory but competes for the same sponsor/CRO recruitment budgets with a much broader portfolio.
• ClinicalTrials.gov: ClinicalTrials.gov is the official U.S. government registry of clinical studies and the source of Hipa.ai's AACT data. As a free comprehensive listing source, it is the primary incumbent Hipa.ai differentiates against via UX, state/city pages, and sponsor services.

Regional players

• Mass General Brigham Biobank Portal: Academic medical center-affiliated trial portals provide condition- and institution-based trial discovery for their patient populations. They compete with Hipa.ai in trial discovery but primarily within their institution's catchment area.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hipa.ai